간이식 수술 전후 예방적 항생제 ampicillin/sulbactam의 적절성 평가
Appropriateness of Ampicillin/sulbactam as Prophylactic Antibiotics in Liver Transplantation
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The most common complication after liver transplantation (LT) is bacterial infection. The incidence of surgical site infections (SSIs) after LT was variable from 8.8%~37%. However, there has been no confirmed guideline in use of prophylactic antibiotics after LT. Ampicillin/sulbactam has been used as main prophylactic antibiotics after LT in Seoul National University Hospital (SNUH) according to the center protocol. The purpose of this study was to determine the incidence and risk factors for SSI after LT and to evaluate the appropriateness of prophylactic antibiotics. A total of 211 patients who underwent LT between July 2008 and June 2010 at SUNH were included. During study period, ampicillin/sulbactam was selected as prophylactic antibiotics in 140 patients (66.4%). A total of 43 patients (20.4%) developed infections and the incidence of SSI was noted in 28 patients (13.2%); 10.0% in ampicillin/sulbactam group and 19.4% in other antibiotics (p=0.049). The most common pathogen of SSI was MRSA (13 episodes, 49.4%). In multivariate analysis, choledochojejunostomy (OR: 7.0; 95% CI, 2.4-20.0) and lower serum albumin (OR: 3.7; 95% CI, 1.1-12.9) were found to be risk factors of SSIs. In conclusion, the incidence of SSIs after LT in this population was similar to those in other studies. Therefore, the prophylactic antibiotics protocol in LT at SNUH seems to be appropriate
Abstract
The most common complication after liver transplantation (LT) is bacterial infection. The incidence of surgical site infections (SSIs) after LT was variable from 8.8%~37%. However, there has been no confirmed guideline in use of prophylactic antibiotics after LT. Ampicillin/sulbactam has been used as main prophylactic antibiotics after LT in Seoul National University Hospital (SNUH) according to the center protocol. The purpose of this study was to determine the incidence and risk factors for SSI after LT and to evaluate the appropriateness of prophylactic antibiotics. A total of 211 patients who underwent LT between July 2008 and June 2010 at SUNH were included. During study period, ampicillin/sulbactam was selected as prophylactic antibiotics in 140 patients (66.4%). A total of 43 patients (20.4%) developed infections and the incidence of SSI was noted in 28 patients (13.2%); 10.0% in ampicillin/sulbactam group and 19.4% in other antibiotics (p=0.049). The most common pathogen of SSI was MRSA (13 episodes, 49.4%). In multivariate analysis, choledochojejunostomy (OR: 7.0; 95% CI, 2.4-20.0) and lower serum albumin (OR: 3.7; 95% CI, 1.1-12.9) were found to be risk factors of SSIs. In conclusion, the incidence of SSIs after LT in this population was similar to those in other studies. Therefore, the prophylactic antibiotics protocol in LT at SNUH seems to be appropriate
참고문헌 (21)
- Fishman JA, "Infection in Solid-Organ Transplant Recipients", N Engl J Med, 357, pp.2601~2614 (2007)
- Asensio A, "Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant", Liver Transpl, 14(6), pp.799~805 (2008)
- Blair JE, "Bacterial, mycobacterial, and protozoal infections after liver transplantation-Part I", Liver Transpl, 11(12), pp.1452~1459 (2005)
- Deok-Bog Moon, "Liver Transplantation", Gut and Liver, 3(3), pp.145~165 (2009), 거트앤리버 발행위원회
- Edwards JR, "National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009", Am J Infect Control, 37(10), pp.783~805 (2009)
- Garcia Prado ME, "Surgical site infection in liver transplant recipients: impact of the type of perioperative prophylaxis", Transplantation, 85(12), pp.1849~ (2008)
- Patel R, "Infections in solid-organ transplant recipients", Clin Microbiol Rev, 10, pp.86~124 (1997)
- Gurusamy KS, "Methods of preventing bacterial sepsis and wound complications for liver transplantation", Cochrane Database Syst Rev, 8(4), pp.CD006660~ (2008)
- Rubin RH, "The direct and indirect effects of infection in liver transplantation: Pathogenesis, impact, and clinical management", Curr Clin Top Infect Dis, 22, pp.125~154 (2002)
- Vandecasteele E, "Antimicrobial prophylaxis in liver transplant patients - a multicenter survey endorsed by the European Liver and Intestine Transplant Association", Transpl Int, 23(2), pp.182~190 (2010)
- Nichols RL, "Preventing surgical site infections: a surgeon's perspective", Emerg Infect Dis, 7(2), pp.220~ (2001)
- Iinuma Y, "Surgical Site Infection in Living-Donor Liver Transplant Recipients: A Prospective Study", Transplantation, 78(5), pp.704~709 (2004)
- Horan TC, "CDC", NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting, 2008, pp.36, 309~332
- American Society of Health-System Pharmacits, "ASHP therapeutic guideline on antimicrobial prophylaxis in surgery", Am J Health-Syst Pharm, 56, pp.1839~ (1999)
- 서옥경, "급성 비천공성 충수염 수술시 예방적 항균제의 사용기간", 한국임상약학회지, 12(2), pp.65~70 (2002), 한국임상약학회
- 장혜경, "수술시 예방적 항균제 사용에 대한 실태조사 및 평가", 한국병원약사회지, 13(3), pp.256~265 (1996)
- Kim YJ, "Epidemiological Data on Antibiotic-resistant Bacteria Isolated in Liver Transplant Recipients", J Korean Soc Transplant, 22, pp.203~208 (2008)
- Chang FY, "Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients", Transplantation, 65, pp.1169~1172 (1998)
- Singh N, "Methicillin-resistant Staphylococcus aureus: The other emerging resistant grampositive coccus among liver transplant recipients", Clin Infect Dis, 30, pp.322~327 (2000)
- Hollenbeak, CS, "The effect of surgical site infections on outcomes and resource utilization after liver transplantation", Surgery, 130(2), pp.388~395 (2001)
- Arnow PM, "Pathogenesis of early operative site infections after orthotopic liver transplantation", Transplantation, 65, pp.1500~1503 (1998)